#1 Clinical Trials Search in Europe

Thiamine Nitrate Bp

This article examines the use of Thiamine Nitrate BP, a component of Concavit Capsules, in clinical trials for Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM). While the primary focus of the trial is on eplontersen, Concavit Capsules, which contain Thiamine Nitrate BP among other vitamins, are being used as a supplementary treatment. This study aims to assess the long-term safety and efficacy of the treatment in patients with ATTR-CM.

Table of Contents

What is Thiamine Nitrate BP?

Thiamine Nitrate BP, also known as Vitamin B1, is an essential nutrient that plays a crucial role in maintaining overall health[1]. The “BP” in its name stands for “British Pharmacopoeia,” which indicates that it meets specific quality standards. Thiamine Nitrate is one of the active ingredients found in Concavit Capsules, a multivitamin supplement.

Uses and Benefits

Thiamine Nitrate BP is primarily used to prevent or treat thiamine deficiency. It has several important functions in the body:

  • Energy metabolism: Thiamine helps convert carbohydrates into energy, which is essential for proper cellular function[1].
  • Nervous system health: It plays a crucial role in maintaining a healthy nervous system[1].
  • Heart function: Thiamine is important for proper heart function and may help support cardiovascular health[1].
  • Brain function: It is essential for cognitive function and may help improve memory and concentration[1].

Administration

Thiamine Nitrate BP is typically taken orally as part of a multivitamin supplement. In the context of the clinical trial mentioned, it is included in Concavit Capsules, which are used as an auxiliary treatment[1]. The capsules are designed for oral use, meaning they should be swallowed with water or as directed by a healthcare professional.

Other Ingredients in Concavit Capsules

Concavit Capsules contain several other vitamins and nutrients along with Thiamine Nitrate BP. These include:

  • Ergocalciferol BP (Vitamin D2): Helps with calcium absorption and bone health[1].
  • Nicotinamide BP (Vitamin B3): Important for energy metabolism and skin health[1].
  • Riboflavin BP (Vitamin B2): Helps with energy production and acts as an antioxidant[1].
  • All-rac-alpha-tocopheryl acetate BP (Vitamin E): An antioxidant that supports immune function and skin health[1].
  • Calcium Pantothenate BP (Vitamin B5): Important for energy metabolism and hormone synthesis[1].
  • Vitamin A BP: Essential for vision, immune function, and skin health[1].
  • Ascorbic Acid BP (Vitamin C): An antioxidant important for immune function and skin health[1].
  • Pyridoxine Hydrochloride BP (Vitamin B6): Important for brain development and function[1].

Safety and Precautions

While Thiamine Nitrate BP and the other vitamins in Concavit Capsules are generally considered safe when taken as directed, it’s important to keep the following in mind:

  • Always follow the dosage instructions provided by your healthcare provider or on the product label[1].
  • Inform your doctor about all medications and supplements you’re taking to avoid potential interactions[1].
  • If you experience any unusual symptoms or side effects, contact your healthcare provider immediately[1].
  • Vitamin supplements are not intended to replace a balanced diet. They should be used to complement a healthy lifestyle[1].

Remember, while Thiamine Nitrate BP and other vitamins are important for health, they should be taken under the guidance of a healthcare professional, especially if you’re participating in a clinical trial or have specific health conditions[1].

Aspect Details
Study Type Open-label extension study
Main Drug Eplontersen (ION-682884)
Supplementary Treatment Concavit Capsules (containing Thiamine Nitrate BP and other vitamins)
Condition Studied Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Primary Objectives Evaluate safety and tolerability of extended dosing with eplontersen
Secondary Objectives Assess efficacy parameters in overall population and subgroups
Key Assessments Safety lab tests, clinical tests, biomarkers, echocardiogram, quality of life questionnaires
Maximum Treatment Duration 36 months

FAQ

  • What is Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)? ATTR-CM is a condition where abnormal proteins called amyloids build up in the heart, affecting its function. This can lead to heart failure and other cardiac problems.
  • What is the purpose of using Thiamine Nitrate BP in this clinical trial? Thiamine Nitrate BP is a component of Concavit Capsules, which are being used as a supplementary treatment in this trial. The main focus is on eplontersen, but the vitamins in Concavit Capsules may provide additional support for patients with ATTR-CM.
  • How long does the clinical trial last? The trial can last up to 36 months (3 years) for each participant, as indicated by the maximum treatment period mentioned in the trial information.
  • What are the main objectives of this clinical trial? The main objectives are to evaluate the safety and tolerability of extended dosing with eplontersen in subjects with ATTR-CM, and to assess various efficacy parameters in the overall population and specific subgroups.
  • What are some of the inclusion criteria for participating in this trial? Participants must have completed the treatment period and end of treatment visit of the previous study (Index Study) or have a diagnosis of ATTR-CM and satisfactory participation in another specific study. They must also be willing to adhere to vitamin A supplementation as per the protocol.

Ongoing Clinical Trials on Thiamine Nitrate Bp

  • Study on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +6

Glossary

  • Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM): A heart condition where abnormal proteins called amyloids, specifically transthyretin, build up in the heart tissue, affecting its function and potentially leading to heart failure.
  • Eplontersen: The main drug being studied in this clinical trial for the treatment of ATTR-CM.
  • Thiamine Nitrate BP: A form of vitamin B1 that is included in Concavit Capsules, used as a supplementary treatment in this trial.
  • Open-label extension study: A type of clinical trial where both researchers and participants know which treatment is being administered, often following a previous study to gather long-term data.
  • Biomarkers: Measurable indicators in the body that can be used to assess the presence or progress of a disease or the effects of a treatment.
  • Echocardiogram (ECHO): A test that uses sound waves to create images of the heart, allowing doctors to evaluate its structure and function.
  • Quality of Life assessment: Questionnaires or tests used to measure how a disease or treatment affects a person's daily life and well-being.
  • Adverse Event (AE): Any unfavorable or unintended sign, symptom, or disease that occurs during a clinical trial, whether or not it is related to the treatment being studied.
  • Anti-drug Antibody (ADA): Proteins produced by the immune system that specifically target and potentially neutralize a therapeutic drug.

References

  1. http://clinicaltrials.eu/trial/study-on-long-term-safety-of-eplontersen-for-adults-with-transthyretin-mediated-amyloid-cardiomyopathy/